Key facts
- Notable investors include FFL Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Janus Rx
- ·The full record, as it builds
Funding rounds
No funding rounds for Janus Rx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Janus Rx
Operator of a long-term care pharmacy intended to serve mental and behavioral health communities. The company provides specialized medication management tailored to the complexities of mental health care, residential care, discharge support, outpatient medicine and on-site administration of long-acting injectables, thereby ensuring optimal and consistent support at every stage of treatment.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Montgomery, AL, United States
- Founded
- 2016
- Employees
- 56
- Website
- januspharmacy.com/
- Ownership
- Privately Held (backing)
Janus Rx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Janus Rx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Janus Rx in its N-PORT filings yet. We sweep new filings monthly.